Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, Phase 3 randomized, placebo-controlled study designed to evaluate
adalimumab in children 4 to 17 years old with polyarticular juvenile idiopathic arthritis
(JIA) who are either methotrexate (MTX) treated or non-MTX treated.